{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:31:28Z","timestamp":1792099888553,"version":"4.4.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,3,1]]},"DOI":"10.1093\/ndt\/15.3.389","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:37:35Z","timestamp":1027723055000},"page":"389-395","source":"Crossref","is-referenced-by-count":53,"title":["Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients"],"prefix":"10.1093","volume":"15","author":[{"given":"Marion","family":"Morena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Cristol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Dantoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Annette","family":"Carbonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Descomps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Canaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,3]]},"reference":[{"key":"key\n\t\t\t\t20180202234806_R1","doi-asserted-by":"crossref","unstructured":"Lindner A, Charra B, Sherrard D, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med1974; 290: 697\u2013701","DOI":"10.1056\/NEJM197403282901301"},{"key":"key\n\t\t\t\t20180202234806_R2","doi-asserted-by":"crossref","unstructured":"Braun WE. Long term complications of renal transplantation. Kidney Int1990; 37: 1363\u20131378","DOI":"10.1038\/ki.1990.123"},{"key":"key\n\t\t\t\t20180202234806_R3","doi-asserted-by":"crossref","unstructured":"London GM, Dr\u00fceke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int1997; 51: 1678\u20131695","DOI":"10.1038\/ki.1997.233"},{"key":"key\n\t\t\t\t20180202234806_R4","doi-asserted-by":"crossref","unstructured":"Chan MK, Varghese Z, Moorhead JF. Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int1981; 19: 625\u2013637","DOI":"10.1038\/ki.1981.62"},{"key":"key\n\t\t\t\t20180202234806_R5","doi-asserted-by":"crossref","unstructured":"Attman PO, Alaupovic P. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia. Relation to renal function and dialysis. Nephron1991; 57: 401\u2013410","DOI":"10.1159\/000186303"},{"key":"key\n\t\t\t\t20180202234806_R6","unstructured":"Sutherland WHF, Corboy J, Walker RJ, Robertson MC, Ball MJ. Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant. Nephrol Dial Transplant1995; 10: 358\u2013365"},{"key":"key\n\t\t\t\t20180202234806_R7","doi-asserted-by":"crossref","unstructured":"Rajman I, Harper L, McPake D, Kendall M, Wheeler D. Low-density lipoprotein subfraction profiles in chronic renal failure. Nephrol Dial Transplant1998; 13: 2281\u20132287","DOI":"10.1093\/ndt\/13.9.2281"},{"key":"key\n\t\t\t\t20180202234806_R8","unstructured":"O'Neal D, Lee P, Murphy B, Best J. Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis. Am J Kidney Dis1996; 49: 488\u2013493"},{"key":"key\n\t\t\t\t20180202234806_R9","doi-asserted-by":"crossref","unstructured":"Dejager S, Bruckert E, Chapman MJ. Dense low-density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res1993; 34: 295\u2013308","DOI":"10.1016\/S0022-2275(20)40756-4"},{"key":"key\n\t\t\t\t20180202234806_R10","unstructured":"Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER. Oxidative stress in haemodialysis. Q J Med1994; 87: 679\u2013683"},{"key":"key\n\t\t\t\t20180202234806_R11","doi-asserted-by":"crossref","unstructured":"Paul JL, Sall ND, Soni . et al. Lipid peroxidation abnormalities in hemodialysed patients. Nephron1993; 64: 106\u2013109","DOI":"10.1159\/000187287"},{"key":"key\n\t\t\t\t20180202234806_R12","unstructured":"Saint-Georges MD, Bonnefont DJ, Bourely BA et al. Selenium deficiency correction in hemodialysed patients. Kidney Int1989; 27: S274\u2013S277"},{"key":"key\n\t\t\t\t20180202234806_R13","unstructured":"Cristol JP, Canaud B, Rabesandratana H, Gaillard I, Serre A, Mion C. Enhancement of reactive oxygen species production and cell surface markers expression during haemodialysis. Nephrol Dial Transplant1994; 9: 389\u2013394"},{"key":"key\n\t\t\t\t20180202234806_R14","doi-asserted-by":"crossref","unstructured":"Himmelfarl J, Lazarus M, Hakim R. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis1991; 17: 271\u2013276","DOI":"10.1016\/S0272-6386(12)80473-2"},{"key":"key\n\t\t\t\t20180202234806_R15","doi-asserted-by":"crossref","unstructured":"Witko-Sarsat V, Friedlander M, Capeillere-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int1996; 49: 1304\u20131313","DOI":"10.1038\/ki.1996.186"},{"key":"key\n\t\t\t\t20180202234806_R16","doi-asserted-by":"crossref","unstructured":"Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J1997; 324 (Pt 1): 1\u201318","DOI":"10.1042\/bj3240001"},{"key":"key\n\t\t\t\t20180202234806_R17","doi-asserted-by":"crossref","unstructured":"Witko-Sarsat V, Friedlander M, Nguyen Khoa T et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol1998; 161: 2524\u20132532","DOI":"10.4049\/jimmunol.161.5.2524"},{"key":"key\n\t\t\t\t20180202234806_R18","doi-asserted-by":"crossref","unstructured":"Witko-Sarsat V, Nguyen-Khoa T, Jungers P, Drueke TB, Descamps-Latscha B. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant1999; 14 [Suppl 1]: 76\u201378","DOI":"10.1093\/ndt\/14.suppl_1.76"},{"key":"key\n\t\t\t\t20180202234806_R19","unstructured":"Miyata T., Kurokawa K., van Ypersele de Strihou C. Carbonyl stress and long-term uremic complications. Adv Nephrol Necker Hosp1998; 28: 311\u2013319"},{"key":"key\n\t\t\t\t20180202234806_R20","doi-asserted-by":"crossref","unstructured":"Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med1996; 21: 845\u2013853","DOI":"10.1016\/0891-5849(96)00233-X"},{"key":"key\n\t\t\t\t20180202234806_R21","doi-asserted-by":"crossref","unstructured":"Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyong cholesterol. Modifications of low-density lipoproteins that increase its atherogenicity. N Engl J Med1989; 320: 915\u2013924","DOI":"10.1056\/NEJM198904063201407"},{"key":"key\n\t\t\t\t20180202234806_R22","doi-asserted-by":"crossref","unstructured":"Esterbauer H, Gebicki J, Puhl H, J\u00fcrgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med1992; 13: 341\u2013390","DOI":"10.1016\/0891-5849(92)90181-F"},{"key":"key\n\t\t\t\t20180202234806_R23","doi-asserted-by":"crossref","unstructured":"Ross R. Atherosclerosis- an inflammatory disease. N Engl J Med1999; 340: 115\u2013126","DOI":"10.1056\/NEJM199901143400207"},{"key":"key\n\t\t\t\t20180202234806_R24","doi-asserted-by":"crossref","unstructured":"Maggi E, Bellazzi R, Falaschi F et al. Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int1994; 45: 876\u2013883","DOI":"10.1038\/ki.1994.115"},{"key":"key\n\t\t\t\t20180202234806_R25","doi-asserted-by":"crossref","unstructured":"Sutherland W, Walker R, Ball M, Stapley S, Robertson M. Oxidation of low-density lipoproteins from patients with renal failure or renal transplants. Kidney Int1995; 48: 227\u2013236","DOI":"10.1038\/ki.1995.288"},{"key":"key\n\t\t\t\t20180202234806_R26","doi-asserted-by":"crossref","unstructured":"Loughrey CM, Young IS, McEneny J et al. Oxidation of low-density lipoprotein in patients on regular haemodialysis. Atherosclerosis1994; 110: 185\u2013193","DOI":"10.1016\/0021-9150(94)90203-8"},{"key":"key\n\t\t\t\t20180202234806_R27","doi-asserted-by":"crossref","unstructured":"Westhuysen J, Saltissi D, Healy H. Oxidation of low-density lipoprotein in hemodialysis patients: effect of dialysis and comparison with matched controls. Atherosclerosis1997; 129: 199\u2013205","DOI":"10.1016\/S0021-9150(96)06040-6"},{"key":"key\n\t\t\t\t20180202234806_R28","unstructured":"Panzetta O, Cominacini L, Garbin U et al. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance haemodialysis: effects of fish oil and vitamin E administration. Clin Nephrol1995; 44: 303\u2013309"},{"key":"key\n\t\t\t\t20180202234806_R29","doi-asserted-by":"crossref","unstructured":"Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett1991; 286: 152\u2013154","DOI":"10.1016\/0014-5793(91)80962-3"},{"key":"key\n\t\t\t\t20180202234806_R30","doi-asserted-by":"crossref","unstructured":"Klimov AN, Gurevich VS, Nikiforova AA et al. Antioxidative activity of high-density lipoproteins in vivo. Atherosclerosis1993; 100: 13\u201318","DOI":"10.1016\/0021-9150(93)90063-Z"},{"key":"key\n\t\t\t\t20180202234806_R31","doi-asserted-by":"crossref","unstructured":"Schiavon R, De Fanti E, Giavarina D, Biasoli S, Cavalcanti G, Guidi G. Serum paraoxonase activity is decreased in uremic patients. Clin Chim Acta1996; 247: 71\u201380","DOI":"10.1016\/0009-8981(95)06221-1"},{"key":"key\n\t\t\t\t20180202234806_R32","doi-asserted-by":"crossref","unstructured":"Dantoine TF, Debord J, Charmes JP et al. Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol1998; 9: 2082\u20132088","DOI":"10.1681\/ASN.V9112082"},{"key":"key\n\t\t\t\t20180202234806_R33","doi-asserted-by":"crossref","unstructured":"Hasselwander O, McMaster D, Fogarty DG, Maxwell AP, Nicholls DP, Young IS. Serum paraoxonase and platelet-activating factor acetylhydrolase in chronic renal failure. Clin Chem1998; 44: 179\u2013181","DOI":"10.1093\/clinchem\/44.1.179"},{"key":"key\n\t\t\t\t20180202234806_R34","doi-asserted-by":"crossref","unstructured":"Cristol JP, Bosc JY, Badiou S et al. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. Nephrol Dial Transplant1997; 12: 2312\u20132317","DOI":"10.1093\/ndt\/12.11.2312"},{"key":"key\n\t\t\t\t20180202234806_R35","doi-asserted-by":"crossref","unstructured":"Verne N, Schumaker D, Puppione L. Sequential flotation ultracentrifugation. Methods Enzymol1986; 128: 155\u2013170","DOI":"10.1016\/0076-6879(86)28066-0"},{"key":"key\n\t\t\t\t20180202234806_R36","doi-asserted-by":"crossref","unstructured":"Gieseg SP, Esterbauer H. Low-density lipoprotein is saturable by pro-oxidant copper. FEBS Lett1994; 343: 188\u2013194","DOI":"10.1016\/0014-5793(94)80553-9"},{"key":"key\n\t\t\t\t20180202234806_R37","doi-asserted-by":"crossref","unstructured":"Esterbauer H, Striegl G, Pulh H, Rothender M. Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radic Res Comm1989; 6: 67\u201375","DOI":"10.3109\/10715768909073429"},{"key":"key\n\t\t\t\t20180202234806_R38","doi-asserted-by":"crossref","unstructured":"Morena M, Vaussenat F, Maggi MF, Canaud B, Cristol JP, Descomps B. Mod\u00e9lisation de la cin\u00e9tique d'oxydation des LDL par un logiciel (logiciel NELOP) et validation dans une population \u00e0 risques vasculaires. C R Soc Biol1999; 193 (2): 211\u2013217","DOI":"10.1051\/jbio\/1999193020211"},{"key":"key\n\t\t\t\t20180202234806_R39","unstructured":"Chan MK, Varghese Z, Persaud JW, Baillod RA, Moorhead JF. Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis. The relative pathogenetic roles of triglyceride production and triglyceride removal. Clin Nephrol1982; 17: 183\u2013190"},{"key":"key\n\t\t\t\t20180202234806_R40","doi-asserted-by":"crossref","unstructured":"Cattran DC, Fenton SSA, Wilson DR, Steiner G. Defective triglyceride removal in lipemia associated with peritoneal dialysis and hemodialysis. Ann Intern Med1976; 85: 29\u201333","DOI":"10.7326\/0003-4819-85-1-29"},{"key":"key\n\t\t\t\t20180202234806_R41","doi-asserted-by":"crossref","unstructured":"Senti M, Romero R, Pedro-Botet J, Pelegri A, Nogues X, Rubies-Prat J. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int1992; 41: 1394\u20131399","DOI":"10.1038\/ki.1992.204"},{"key":"key\n\t\t\t\t20180202234806_R42","doi-asserted-by":"crossref","unstructured":"Rajman I, Maxwell S, Cramb R, Kendall M. Particle size: the key to the atherogenic lipoprotein? Q J Med1994; 87: 709\u2013720","DOI":"10.1093\/oxfordjournals.qjmed.a068888"},{"key":"key\n\t\t\t\t20180202234806_R43","doi-asserted-by":"crossref","unstructured":"Chapman MJ, Bruckert E. The atherogenic role of triglycerides and small, dense low-density lipoproteins: impact of ciprofibrate therapy. Atherosclerosis1996; 124 [Suppl]: S21\u201328","DOI":"10.1016\/0021-9150(96)05853-4"},{"key":"key\n\t\t\t\t20180202234806_R44","doi-asserted-by":"crossref","unstructured":"Sevanian A, Hwang J, Hodis H, Cazzolato G, Avogaro P, Bittolo-Bon G. Contribution of in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations. Arterioscler Thromb Vasc Biol1996; 16: 784\u2013793","DOI":"10.1161\/01.ATV.16.6.784"},{"key":"key\n\t\t\t\t20180202234806_R45","doi-asserted-by":"crossref","unstructured":"Klimov AN, Kozhemiakin LA, Pleskov VM, Andreeva LI. Antioxidative effect of high-density lipoproteins in the oxidation of low-density lipoproteins. Biull Eksp Biol Med1987; 103: 550\u2013552","DOI":"10.1007\/BF00841817"},{"key":"key\n\t\t\t\t20180202234806_R46","doi-asserted-by":"crossref","unstructured":"Mackness MI, Durrington PN. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis1995; 115: 243\u2013253","DOI":"10.1016\/0021-9150(94)05524-M"},{"key":"key\n\t\t\t\t20180202234806_R47","doi-asserted-by":"crossref","unstructured":"Mackness MI, Arrol S, Abbott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis1993; 104: 129\u2013135","DOI":"10.1016\/0021-9150(93)90183-U"},{"key":"key\n\t\t\t\t20180202234806_R48","doi-asserted-by":"crossref","unstructured":"Mackness MI, Harty D, Bhatnagar D et al. Serum paraoxonase activity in familial hypercholesterolemia and insulin-dependent diabetes mellitus. Atherosclerosis1991; 86: 193\u2013199","DOI":"10.1016\/0021-9150(91)90215-O"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/15\/3\/389\/23770507\/150389.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T04:10:57Z","timestamp":1682223057000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/15\/3\/389\/1805268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,1]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2000,3]]},"published-print":{"date-parts":[[2000,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/15.3.389","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,3]]},"published":{"date-parts":[[2000,3,1]]}}}